Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06741527

Integrity Implant System Post Market Clinical Follow-Up Study

The study design is a prospective, multi-center, single-arm, non-randomized post market clinical follow-up study to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

OrthoArizona, Gilbert, Arizona, United States

Loading trial locations.

About this study

The Study Objective is to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).

The clinical success will be evaluated by absence of rotator cuff re-tear. Performance and clinical benefits will be evaluated by functional outcomes measured using standard scoring systems such as the American Shoulder and Elbow Surgeons Shoulder Score (ASES), Constant-Murley Score (CMS), Patient Satisfaction, EQ-5D-5L, Single Assessment Numeric Evaluation (SANE), Visual Analogue Scale (VAS) and rotator cuff repair outcomes measured using MRI evaluation for repair integrity, quality, tendon tissue thickness and regeneration.

Safety of the Integrity Implant System will be assessed by monitoring the frequency and incidence of adverse events.

The Primary Endpoint shall confirm the Performance of the Integrity Implant System when used for rotator cuff augmentation (with or without repair). Performance will be evaluated by an adequately powered analysis of retear rates seen by MRI at 12-months after surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

  • At least 18 years of age
  • Able (with assistance from LAR, if necessary) to understand the informed consent process, including regulatory requirements such as HIPAA authorization, and document informed consent prior to completion of any study-related procedures.
  • Able to complete all Patient Reported Outcome Measure (PROM) questionnaires.
  • Fully understands study requirements and able to return for all required follow-up visits and assessments.
  • Able to comply with all post-operative physician prescribed rehabilitation instructions.
  • Index shoulder rotator cuff tendon tear surgical access may be performed using mini-open, single-portal arthroscopic or multi-portal arthroscopic intervention
  • Meets all intended use and indications for use defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include:

Index shoulder rotator cuff tendon tear needs management and protection from injury

Index shoulder has no substantial loss of tendon tissue

Index shoulder rotator cuff tendon tear footprint allows approximation of soft tissue and fixation of the Integrity Implant to tendon tissue using an Integrity Tissue Tack

Index shoulder rotator cuff tendon tear footprint allows fixation of the Integrity Implant to bone using the Integrity Bone Staple

Exclusion criteria

The subject exclusion criteria are as follows:

  • Medical condition that in the PI's opinion would place the subject at risk or interfere with the study
  • Vulnerable population (prisoners, minors, pregnant women, mentally ill persons and the elderly or any person under any undue pressure from others to participate in the study)
  • Pregnant, breastfeeding, or plans to become pregnant during the study
  • History of poor compliance with medical treatment of any kind
  • Deemed contraindicated for MRI by the PI
  • Previous rotator cuff surgery (any type) on the index shoulder
  • Current instability of the index shoulder
  • Rotator cuff tendon tear is a Massive Cofield Classified Full-Thickness Tear (tear length >5cm)
  • Chondromalacia of index shoulder ≥ Grade 3
  • Fatty infiltration of the index shoulder rotator cuff muscle ≥ Grade 3
  • Insulin dependent Type I Diabetes
  • History of heavy smoking (≥ 1 pack per day) within last 6-months
  • History of auto-immune or immunodeficiency disorders
  • Currently taking immunosuppression medication for other diseases (e.g., transplants or other inflammatory diseases)
  • Oral steroid use in the last 2-months or injectable steroid use in the last 3-months
  • History of cognitive or mental health status that interferes with study participation
  • Poor comprehension of English language
  • Meets one or more of the contraindications defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include:

18.1 Rotator cuff tendon tear is deemed irreparable by the PI

18.2 Rotator cuff tendon tear repair requires replacement of damaged tendon

18.3 Rotator cuff tendon tear repair requires fixation of soft tissue to adjoining soft tissue

18.4 Rotator cuff tendon tear repair requires tendon strength reinforcement

18.5 Presence of infection

18.6 Any condition which would limit the ability or willingness to restrict activities or follow directions during the healing period

18.7 Hypersensitivity to any of the Integrity Implant System components

18.8 Inadequate soft tissue support for Integrity Tissue Tack fixation

18.9 Inadequate quality of bone for Integrity Bone Staple fixation

Treatment and study plan

Integrity Implant System

Device

Integrity Implant System used for Rotator Cuff Repair

Primary outcomes

  1. Re-tear rate after rotator cuff augmentation

    Time frame: 12 months postoperatively

    Assessed by MRI evaluation at 12 months post-operatively defined using Sugaya classification system.

Secondary outcomes

  1. The American Shoulder and Elbow Surgeons (ASES) Score

    Time frame: Screening/Pre-Op, 6 weeks, 6-month, 12-month and 24-month Post-operatively

    The American Shoulder and Elbow Surgeon's (ASES) Score is a tool used to measure shoulder function. The ASES score is on a scale of 0 to 100, with 0 being the worst possible score and 100 the best. The score consists of two components - pain and activities of daily living.

  2. Constant-Murley Score (CMS)

    Time frame: Screening/Pre-Op, 6 weeks, 6-month, 12-month and 24-month post-operatively

    The Constant-Murley Shoulder Score is a scoring method used by clinicians to assess function of the shoulder. The standard score is on a scale of 0 to 100, with 0 being no shoulder function and 100 being excellent function.

  3. EQ-5D-5L (EuroQol)

    Time frame: Screening/Pre-Op, 6 weeks, 6-month, 12-month and 24-month post-operatively

    The 5-level EQ-5D (EQ-5D-5L) is a standardized self-assessed, health related quality of life questionnaire. It is composed of five questions with Likert scale response options (descriptive system) and a visual analog scale (EQ-VAS). The EQ-VAS asks patients to rate their own health from 0 to 100 (the worst and best imaginable health, respectively).

  4. The Single Assessment Numeric Evaluation (SANE) Score

    Time frame: Screening/Pre-Op, 6 weeks, 6-month, 12-month and 24-month post-operatively

    The Single Assessment Numeric Evaluation (SANE) Score is a tool used to assess the subject's perception of their affected joint. Participants are requested to rate their shoulder function on a scale of 0 to 100, with 0 as the worst option and 100 being normal shoulder function.

Study contacts

Contact information is provided by the study sponsor or research team.

Jennifer Williams

CONTACT

[email protected]

781-457-9000

Kara Mezger

CONTACT

[email protected]

781-457-9000

Sponsors and collaborators

Lead sponsor

Anika Therapeutics, Inc.

Industry

Registry information

Official study title

Post Market Confirmatory Interventional Clinical Study of the Integrity Implant System Used for Rotator Cuff Tear Augmentation

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Dec 19, 2024
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.